Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00334243 · ClinicalTrials.gov registry record · Phase 4

Protocols for Improved in Vitro Fertilization (IVF) Outcomes

A Phase 4 study, sponsored by University of California, San Francisco.

Terminated
Registry status
Phase 4
Development phase
2
Enrollment target

NCT00334243 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00334243, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.

TERMINATED
Registry status
Phase 4
Development phase
2 participants
Enrollment target

Study Summary

Many infertile patients have a decreased chance of becoming pregnant when using in vitro fertilization (IVF). For these patients, many different treatments are available, but none of them have been shown to be better than the others. We are testing which of three different treatments are better than the others. Patients who are expected to have a decreased response to ovarian stimulation will be randomized to either a microflare protocol, an antagonist protocol, or a demi-halt protocol.

Interventions

  • DRUG Microflare protocol for IVF
  • DRUG Antagonist protocol for IVF
  • DRUG Demi-halt protocol for IVF

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2006-06
Est. Completion 2007-11
Phase Phase 4

What the Registry Record Tells You About NCT00334243

The ClinicalTrials.gov registry entry for NCT00334243 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Microflare protocol for IVF is the first listed.

NCT00334243 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00334243 about?

NCT00334243 is a clinical study titled "Protocols for Improved in Vitro Fertilization (IVF) Outcomes". Many infertile patients have a decreased chance of becoming pregnant when using in vitro fertilization (IVF). For these patients, many different treatments are available, but none of them have been shown to be better than the others. We are testing which of three different treatments are better than...

What is the current status of trial NCT00334243?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2006-06. Estimated completion is 2007-11.

What interventions are being tested in trial NCT00334243?

The interventions under investigation include: Microflare protocol for IVF (DRUG), Antagonist protocol for IVF (DRUG), Demi-halt protocol for IVF (DRUG).

Who is sponsoring clinical trial NCT00334243?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.